statements

Jeena Sikho Lifecare Ltd.

NSE: JSLL

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

511.30+5.9 (+1.18%)

24 Aug, 3:30 PM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Jeena Sikho Lifecare Ltd. income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M PRESS	12M IR
Total Revenue	105.82	94.42	135.81	146.45	204.75	324.41	469.07	801.36	851.48
Cost of Operating Revenue	23.77	14.12	18.66	18.42	20.60	26.66	39.97	139.22	152.29
Gross Profit	82.05	80.29	117.15	128.04	184.15	297.75	429.10	662.14	699.19
Gross Margin	77.5	85.0	86.3	87.4	89.9	91.8	91.5	82.6	82.1
Total Operating Expenses	96.41	85.82	121.46	131.63	162.35	236.52	352.91	499.63	542.18
Operating Profit	9.41	8.59	14.35	14.82	42.40	87.89	116.16	301.73	309.31
Operating Margin	8.9	9.1	10.6	10.1	20.7	27.1	24.8	37.7	36.3
Financing Income/(Expense) - Net	-1.13	-1.64	-1.17	-0.92	1.21	3.40	2.89	-12.83	-14.65
Profit before Taxes	8.33	7.71	13.98	15.17	44.29	93.92	122.07	297.39	316.41
Income Taxes	2.34	1.99	3.83	3.90	10.77	24.71	31.34	75.70	80.10
Profit after Tax	6.00	5.73	10.16	11.27	33.78	69.21	90.73	221.85	236.49
PAT Margin	5.7	6.1	7.5	7.7	16.5	21.3	19.3	27.7	27.8
EPS - Basic - ex Extraordinary Items	0.48	0.46	0.82	1.24	2.76	5.57	7.30	17.84	19.02
EPS - Diluted - ex Extraordinary Items	0.48	0.46	0.82	1.24	2.76	5.57	7.30	17.81	18.97
EBIT	9.41	8.59	14.35	14.82	42.40	87.89	116.16	301.73	309.31
EBITDA	10.61	10.53	16.81	18.12	45.60	92.99	124.87	349.42	362.74
EBITDA Margin	10.0	11.2	12.4	12.4	22.3	28.7	26.6	43.6	42.6

Balance Sheet

Abridged

Understanding Balance Sheet

Jeena Sikho Lifecare Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	PR	PR	PR	AR	AR	AR	AR	PRESS
Total Current Assets	23.17	20.91	26.09	22.04	77.48	143.98	152.16	340.87
Long-Term Investments	-	-	-	0.01	-	-	0.64	26.33
Property Plant & Equipment - Net	12.55	16.52	22.50	33.26	60.82	70.76	103.58	234.28
Total Non-Current Assets	12.86	17.12	23.06	39.51	73.55	76.55	176.15	333.37
Total Assets	36.03	38.04	49.15	61.55	151.03	220.53	328.31	674.24
Total Current Liabilities	27.15	23.43	24.28	23.83	24.60	27.41	52.27	104.98
Long Term Debt	0.66	0.50	0.15	0.81	0.54	0.32	0.43	95.75
Total Non-Current Liabilities	0.88	0.88	0.80	1.17	0.63	0.88	3.02	102.31
Total Liabilities	28.03	24.31	25.08	25.00	25.23	28.28	55.29	207.29
Total Shareholders' Equity	8.00	13.73	24.07	36.56	125.80	192.25	273.02	467.08
Minority Interest	-	-	-	-	-	-	-	-0.13
Total Equity	8.00	13.73	24.07	36.56	125.80	192.25	273.02	466.95
Total Liabilities & Equity	36.03	38.04	49.15	61.55	151.03	220.53	328.31	674.24

Cash Flow

Abridged

Understanding Cash Flow Statement

Jeena Sikho Lifecare Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M PR	12M PR	12M PR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	7.60	7.41	12.77	13.65	38.19	70.94	95.31	273.76
Working Capital - Increase/(Decrease)	-6.92	2.45	3.60	2.79	-23.55	-31.59	-24.23	-30.84
Net CF from Operating Activities	0.68	9.86	16.37	16.44	14.64	39.36	71.08	242.92
Capital Expenditures - Net	10.83	5.97	8.60	18.17	29.90	13.86	38.60	32.90
Net CF from Investing Activities	-10.83	-5.97	-8.60	-19.56	-34.09	-21.13	-73.32	-203.46
Dividends Paid - Cash - Total	-	-	-	-	-	2.76	10.38	13.67
Stock - Issuance/(Retirement) - Net	-	-	0.19	1.33	55.50	-	-	-
Debt - LT & ST - Issuance/(Retirement) - Total	7.82	-3.16	-0.43	-4.60	-6.63	-0.27	10.19	-32.40
Net Cash Flow from Financing Activities	7.82	-3.16	-0.24	-3.27	48.87	-3.03	-0.19	-46.07
Free Cash Flow to Equity	-2.32	0.73	7.34	-6.33	-21.89	25.23	42.68	177.62
Free Operating CF net dividend	-10.15	3.89	7.54	-5.35	-23.38	21.06	18.87	194.95
Free Operating CF	-10.15	3.89	7.54	-5.35	-23.38	23.82	29.25	208.62

Business Segment Analysis

FY End:

Mar 25

Jeena Sikho Lifecare Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Trading of Ayurvedic Medicines (100.0%)₹ 41.83 Cr

Revenue / Sales

Trading of Ayurvedic Medicines (100.0%)₹ 469.07 Cr

Assets

Trading of Ayurvedic Medicines (100.0%)₹ 328.31 Cr

Operating Income

Trading of Ayurvedic Medicines (100.0%)₹ 116.16 Cr

Regional Segment Analysis

Jeena Sikho Lifecare Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

We don't have enough data to show regional segment analysis for Jeena Sikho Lifecare Ltd.

Historical Segment Analysis

Track how Jeena Sikho Lifecare Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2019 Mar 31	2020 Mar 31	2021 Mar 31	2025 Mar 31
	2019 Mar 31	2020 Mar 31	2021 Mar 31	2025 Mar 31
Trading of Ayurvedic Medicines	11	6	9	42

Frequently Asked Questions

What is the revenue of Jeena Sikho Lifecare Ltd.?

The latest trailing twelve month revenue of Jeena Sikho Lifecare Ltd. is ₹ 801.36 Cr, reflecting a 1-year growth of 70.84% and a 3-year CAGR of 57.59%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Jeena Sikho Lifecare Ltd.?

The latest trailing twelve month net profit (PAT) of Jeena Sikho Lifecare Ltd. is ₹ 221.85 Cr, with a 3-year earnings CAGR of 86.16%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Jeena Sikho Lifecare Ltd.?

The trailing twelve month EBITDA of Jeena Sikho Lifecare Ltd. is approximately ₹ 301.73 Cr (based on an operating margin of 37.65%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Jeena Sikho Lifecare Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Jeena Sikho Lifecare Ltd. is 17.81. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Jeena Sikho Lifecare Ltd.?

The debt-to-equity ratio of Jeena Sikho Lifecare Ltd. stands at 0.27. The interest coverage ratio is 23.51x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Jeena Sikho Lifecare Ltd.?

The estimated book value per share of Jeena Sikho Lifecare Ltd. is 38.02 (derived from a P/B ratio of 13.45 and market price of ₹ 511.30), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Jeena Sikho Lifecare Ltd.?

The trailing twelve month operating cash flow of Jeena Sikho Lifecare Ltd. is ₹ 242.92 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Jeena Sikho Lifecare Ltd. report consolidated or standalone financials?

Jeena Sikho Lifecare Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.